NVI-100
N/A
Report date: 2025/02/07 17:26:41
NMEFirst In Class
Base Information
Drug NameNVI-100
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesFerring Pharmaceuticals A/S
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A